PRA teams with CISCRP for trial result summaries

By Maggie Lynch contact

- Last updated on GMT

(Image: Getty/ Hero images)
(Image: Getty/ Hero images)

Related tags: Pra, Pra health sciences, Clinical trial, Clinical trial data, Clinical trial management, Patient centricity, patient engagement, Patient outcomes

PRA Health Sciences is collaborating with CISCRP to provide patients with soon to be mandatory clinical trial result summaries.

Plain language trial results will become mandatory for studies conducted in the EU under the EU Clinical Trials Regulation No 536/2014​, which is expected to come into effect in 2020. This act will require sponsors to provide trial results through the European Medicines Agency (EMA) portal and database.

Under its agreement with the Center for Information and Study on Clinical Research Participation (CISCRP), PRA’s medical writers will draft the trial results summaries and CISCRP will coordinate the review of all summaries through its Editorial Panels. These panels will be composed of members of the public as well as patients, patient advocates, and health care specialists in the therapeutic area of the study.

CISCRP also will manage translation into patient languages and facilitate the dissemination to participants through investigative sites.

Jill McNair, senior director of Patient Engagement at CISCRP said in a statement, “This collaboration also helps to further our mission to make the return of plain language trial result summaries a standard practice adopted by the clinical research community.”

According to PRA, approximately 11% of participants currently receive trial results, despite studies showing that a majority of want to know what has been learned from the trial.

PRA Health Services has not responded to a request for comment. 

Related news

Show more

Related products

show more

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 05-Nov-2018 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Baxter’s Oncology Contract Manufacturing

Baxter’s Oncology Contract Manufacturing

Baxter BioPharma Solutions | 29-Aug-2018 | Product Brochure

Baxter BioPharma Solutions’ FOYA award-winning facility in Halle/Westfalen, Germany, offers state-of-the-art parenteral cGMP manufacturing at one location,...

Related suppliers

Follow us

Featured Events

View more

Products

View more

Webinars